丰田料下半年全球产量增5%至460万辆 创同期新高
《共同社》报道,丰田汽车预计下半年全球产量将按年增加5%至约460万辆,创同期新高,虽然上半年因疫情爆发而不得不减产,但下半年将追回产量。
丰田汽车9月全球产量按年增长11.7%,达到84.2万辆的新高,主要由於中国、北美及欧洲等主要市场加大生产,预计10月以後产量亦将继续复苏。
丰田汽车上半年全球产量按年减少28.6%至331万辆,全年预计为790万辆,按年减少约13%;同时预计11月至明年1月的三个月内,全球产量将增长8%至约230万辆,达到历史新高。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.